FDA Inspection 1153267 — Anderson Compounding Pharmacy, Inc.
The FDA completed an inspection of Anderson Compounding Pharmacy, Inc. on Sep 9, 2021 in Bristol, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 9, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bristol, TN (United States)